- Report
- May 2026
- 291 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 196 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 284 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 158 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 291 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 473 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 374 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 279 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 247 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 266 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Report
- May 2026
- 385 Pages
Global
From €5202EUR$5,850USD£4,492GBP
- Clinical Trials
- April 2026
- 60 Pages
Global
From €1334EUR$1,500USD£1,152GBP
- Report
- December 2025
- 200 Pages
Global
From €7070EUR$7,950USD£6,105GBP
- Report
- January 2026
- 180 Pages
Global
From €4002EUR$4,500USD£3,456GBP
- Report
- January 2026
- 180 Pages
Global
From €4002EUR$4,500USD£3,456GBP
- Report
- August 2025
- 180 Pages
Global
From €4002EUR$4,500USD£3,456GBP
- Report
- June 2025
- 189 Pages
Global
From €4002EUR$4,500USD£3,456GBP
- Report
- June 2025
- 183 Pages
Global
From €4002EUR$4,500USD£3,456GBP
- Report
- July 2025
- 350 Pages
Global
From €4401EUR$4,949USD£3,800GBP
- Report
- July 2025
- 350 Pages
Global
From €4401EUR$4,949USD£3,800GBP

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections.
The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more